TY  - RPRT
TI  - Technology evaluation: pertuzumab, Roche/Genentech/Chugai.
AU  - James Spicer
PY  - 2004
UR  - https://pubmed.ncbi.nlm.nih.gov/15264437/
ID  - 15264437
ER  -